Moldova vs Romania: Life science patents granted, by technology
Moldova
15 patents
in 2023
Romania
14 patents
in 2023
Moldova rank
34th
Romania rank
35th
Life science patents granted, by technology over time
- Moldova
- Romania
How they compare
Moldova currently reports 15 patents against 14 patents in Romania, a difference of 1 patents.
That makes Moldova's figure about 1.1 times Romania's.
The two have swapped places 3 times across 30 shared years of data; in 1994 it was Romania ahead.
Moldova ranks 34th and Romania ranks 35th of 65 countries.
Romania has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Moldova | Romania | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 18.5 patents | 54.83 patents | 36.33 patents | Romania |
| 2000s | 24 patents | 51.4 patents | 27.4 patents | Romania |
| 2010s | 20 patents | 29.2 patents | 9.2 patents | Romania |
| 2020s | 19.75 patents | 21.75 patents | 2 patents | Romania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Moldova or Romania?
- Moldova, at 15 patents against 14 patents in Romania as of 2023.
- What is the difference in life science patents granted, by technology between Moldova and Romania?
- 1 patents, with Moldova ahead.
- How many years of comparable data are there for Moldova and Romania?
- 30 years are reported by both, from 1994 to 2023.
- How do Moldova and Romania rank globally for life science patents granted, by technology?
- Moldova ranks 34th and Romania ranks 35th of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) β processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.